Vaccination against human papillomavirus is not associated with resolution of verruca vulgaris in immunocompetent 9- to 21-year olds

J Am Acad Dermatol. 2022 Jul;87(1):250-252. doi: 10.1016/j.jaad.2021.08.016. Epub 2021 Aug 18.

Authors

Yana Kost¹, Alana Deutsch¹, Tian Hao Zhu¹, Imge Hulur¹, Rachel C Blasiak²

Affiliations

¹ Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, New York.
² Department of Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, New York; Division of Dermatology, Jacobi Medical Center, Bronx, New York. Electronic address: rachel_blasiak@med.unc.edu.

PMID: 34418514
DOI: 10.1016/j.jaad.2021.08.016

No abstract available

Keywords: HPV; common warts; human papilloma virus; infection; therapy; vaccine; verruca vulgaris.

MeSH terms

Alphapapillomavirus*
Humans
Papillomaviridae
Papillomavirus Infections* / complications
Vaccination
Warts*